Company profile
Genomics PLC - Genomics plc
Genomics PLC - Genomics plc
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
RP04CS01 | Transaction MzQ1NTcxMTQwM2FkaXF6a2N4
Published 20 Feb 2025 02:22
CS01 | Transaction MzQ1MjAyMzY3OWFkaXF6a2N4 | Paper/PDF filed
Published 22 Feb 2025 05:50
Last accounts made up date
SH01 | Transaction MzQ0NDE0Mzk0N2FkaXF6a2N4
Published 19 Nov 2024 07:13
AP01 | Transaction MzQ0NDE0MzQ5NGFkaXF6a2N4
Published 19 Nov 2024 06:55
RESOLUTIONS | Transaction QURFWkpHMklhZGlxemtjeA | Paper/PDF filed
Published 16 Nov 2024 04:11
MAR | Transaction MzQ0MjM3NTQyOWFkaXF6a2N4 | Paper/PDF filed
Published 16 Nov 2024 04:05
RR02 | Transaction MzQ0MjM3NTIxMmFkaXF6a2N4 | Paper/PDF filed
Published 16 Nov 2024 04:00
CERT10 | Transaction MzQ0MjM3NTQzMGFkaXF6a2N4 | Paper/PDF filed
Published 16 Nov 2024 03:54
Company registered at Companies House
Genomics develops databases and algorithms providing genome sequence data analysis for use in preventative medicine and drug discovery.
From the website: We are aiming to lead the genomic transformation of healthcare Our vision is simple: to fulfil the potential of genomics to change the world We will lead the way through this challenge, using our expertise and experience to unleash the potential of genomics and set the standards by which healthcare professionals can benefit from genomic data.
Secured US$ 15M in funding. Signed collaborations with Vertex Pharmaceuticals; Oxford University and Oxford University Hospitals NHS Trust; Biogen; Eisai Appointed Sekar Kathiresan as Chair of SAB
